STAT3 and colonic neoplasm: Evidence for the latter comes from the observation that all colonic tumours in the CAC-challenged gp130Y757F mice harbour activating mutations in β-catenin, and that gp130Y757F;ApcMin mice show increased tumour multiplicity [68,93], while enterocyte-specific Stat3 ablation reduced tumour incidence in ApcMin mice [33].